Eribulin as a Second-line Treatment in Triple-negative Advanced Breast Cancer
- Status
- UNKNOWN
- Phase
- N/A
Clinical Trials Related to Breast Cancer
Related studies linked through entity extraction aliases.
AC vs TC in Patients With HR-positive, HER2-negative Early Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE4
Tridimensional Geometric Modeling of the Breast
- Status
- COMPLETED
- Phase
- NA
TAP vs QL for Postoperative Analgesia After DIEP Free Flap Breast Reconstruction
- Status
- WITHDRAWN
- Phase
- NA
Trivandrum Breast Cancer Screening Trial
- Status
- COMPLETED
- Phase
- NA
Social Risk Factors and Discrimination in Cancer Survivorship
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
A Clinical Investigation to Confirm the Ability of MammoWave in Breast Lesions Detection
- Status
- RECRUITING
- Phase
- NA
Efficacy of Cilostazol in Prevention of Peripheral Neuropathy
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Identification of Novel Inflammation-related Biomarkers for Early Detection of Anthracycline-induced Cardiotoxicity in Breast Cancer Patients
- Status
- UNKNOWN
- Phase
- N/A
Resistance vs. Aerobic Training on Breast Cancer Patients Undergoing Neoadjuvant Treatment
- Status
- RECRUITING
- Phase
- NA
Deescalation of Endocrine Therapy Duration in Women With HR+ HER2- Breast Cancer at Very Low Risk
- Status
- RECRUITING
- Phase
- PHASE2
Identifying Prognostic Variables for Persistent Upper Limb Dysfunctions After Breast Cancer Treatment
- Status
- RECRUITING
- Phase
- N/A
Anlotinib Combination With Vinorelbine in the HER2- Advanced Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Smart Bra for Diagnosing Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Phase I Study to Evaluate SIM0270 Alone or in Combination in ER+, HER2- Locally Advanced or Metastatic Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Post Marketing Surveillance on Piqray in Korea
- Status
- RECRUITING
- Phase
- N/A
Compare Continuation of Original Targeted Therapy With Trastuzumab Combined With Pyrotinib and Capecitabine as Postoperative Adjuvant Therapy in Non-pCR Patients With HER2 Positive Early Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Inetetamab Combined With Anti-PD-1 Monoclonal Antibody and Albumin-Bound Paclitaxel for HER2+ Metastatic Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4
Feasibility Evaluation of the Muse Magnetic Resonance Guided Focused Ultrasound System
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Adjuvant Chemoradiation and Biomarkers of Response in High-risk Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3